Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Monish Jain, Junying Fan, Nesrine Z Baturay, Chul-Hoon Kwon
Index: J. Med. Chem. 47(15) , 3843-52, (2004)
Full Text: HTML
Abstract
A series of sulfonyl-group containing analogues of aldophosphamide (Aldo) were synthesized as potential anticancer prodrugs that liberate the cytotoxic phosphoramide mustards (PM, IPM, and tetrakis-PM) via beta-elimination, a nonenzymatic activation mechanism. Kinetic studies demonstrated that all these compounds spontaneously liberate phosphoramide mustards with half-lives in the range of 0.08-15.2 h under model physiological conditions in 0.08 M phosphate buffer at pH 7.4 and 37 degrees C. Analogous to Aldo, the rates of beta-elimination in all compounds was enhanced in reconstituted human plasma under same conditions. The compounds were more potent than the corresponding phosphoramide mustards against V-79 Chinese hamster lung fibroblasts in vitro (IC(50) = 1.8-69.1 microM). Several compounds showed excellent in vivo antitumor activity in CD2F1 mice against both P388/0 (Wild) and P388/CPA (CP-resistant) tumor cell lines.
Related Compounds
Related Articles:
1985-09-01
[J. Med. Chem. 28(9) , 1309-13, (1985)]
Mild conversion of electron deficient aryl fluorides to phenols using 2-(methylsulfonyl) ethanol. Rogers JF and Green DF.
[Tetrahedron Lett. 43(19) , 3585-87, (2002)]
Reagent effects on distribution of methylsulfonylethyl substituents in the D-glucopyranosyl unit of cotton cellulose. Rowland SP, et al.
[Can. J. Chem. 46(3) , 451-7, (1968)]